Interestingly, data obtained from quantification of CEMIP in patient samples showed that metastatic tumors with high levels of CEMIP are linked to poor survival when compared to those with low levels of CEMIP [69]. The gene discussed is CEMIP; the disease is metastatic neoplasm.